Twist Bioscience Corporation Earnings Per Share (Basic)
Twist Bioscience Corporation (TWST) reported Earnings Per Share (Basic) of -$0.56 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- Twist Bioscience Corporation earnings per share, basic for the quarter ending 2026-06-30 was -$0.56, a 264.71% decline year-over-year.
- Twist Bioscience Corporation earnings per share, basic for the quarter ending 2026-03-31 was -$0.71.
- Twist Bioscience Corporation earnings per share, basic for the quarter ending 2025-12-31 was -$0.50.
- Twist Bioscience Corporation earnings per share, basic for the quarter ending 2025-09-30 was -$0.45.
- Twist Bioscience Corporation earnings per share, basic for fiscal 2025 was -$1.30.
- Twist Bioscience Corporation earnings per share, basic for fiscal 2024 was -$3.60.
- Twist Bioscience Corporation earnings per share, basic for fiscal 2023 was -$3.60.
- Twist Bioscience Corporation earnings per share, basic for fiscal 2022 was -$4.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.56 10-Q · filed 2026-08-03 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.78 10-Q · filed 2026-08-03 | -$2.23 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | -$0.71 10-Q · filed 2026-05-04 | -$1.21 10-Q · filed 2026-05-04 | -$1.66 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | -$0.50 10-Q/A · filed 2026-02-26 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-09-30 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$1.30 10-K · filed 2025-11-17 |
| 2025-06-30 | $0.34 10-Q · filed 2026-08-03 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$0.85 10-Q · filed 2026-08-03 | -$1.44 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | -$0.66 10-Q · filed 2026-05-04 | -$1.19 10-Q · filed 2026-05-04 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-05-04 | -$3.25 derived: net income ÷ weighted average shares · filed 2026-05-04 |
| 2024-12-31 | -$0.53 10-Q/A · filed 2026-02-26 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$2.59 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$3.38 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-09-30 | -$0.59 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$2.06 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$2.85 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$3.60 10-K · filed 2025-11-17 |
| 2024-06-30 | -$1.47 10-Q · filed 2025-08-04 | -$2.26 derived: net income ÷ weighted average shares · filed 2025-08-04 | -$3.01 10-Q · filed 2025-08-04 | -$3.82 derived: net income ÷ weighted average shares · filed 2025-11-17 |
| 2024-03-31 | -$0.79 10-Q · filed 2025-05-05 | -$1.54 10-Q · filed 2025-05-05 | -$2.34 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$3.35 derived: net income ÷ weighted average shares · filed 2025-11-17 |
| 2023-12-31 | -$0.75 10-Q · filed 2025-02-03 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$2.56 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$3.60 derived: net income ÷ weighted average shares · filed 2025-11-17 |
| 2023-09-30 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$1.81 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$2.85 derived: net income ÷ weighted average shares · filed 2025-11-17 | -$3.60 10-K · filed 2025-11-17 |
| 2023-06-30 | -$1.01 10-Q · filed 2024-08-02 | -$2.05 derived: net income ÷ weighted average shares · filed 2024-08-02 | -$2.79 10-Q · filed 2024-08-02 | -$3.69 derived: net income ÷ weighted average shares · filed 2024-11-18 |
| 2023-03-31 | -$1.04 10-Q · filed 2024-05-02 | -$1.78 10-Q · filed 2024-05-02 | -$2.69 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$3.76 derived: net income ÷ weighted average shares · filed 2024-11-18 |
| 2022-12-31 | -$0.74 10-Q · filed 2024-02-02 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$2.72 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$3.85 derived: net income ÷ weighted average shares · filed 2024-11-18 |
| 2022-09-30 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$3.11 derived: net income ÷ weighted average shares · filed 2024-11-18 | -$4.04 10-K · filed 2024-11-18 |
| 2022-06-30 | -$1.08 10-Q · filed 2023-08-07 | -$2.21 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$3.15 10-Q · filed 2023-08-07 | -$3.98 derived: net income ÷ weighted average shares · filed 2023-11-21 |
| 2022-03-31 | -$1.13 10-Q · filed 2023-05-08 | -$2.06 10-Q · filed 2023-05-08 | -$2.90 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$3.72 derived: net income ÷ weighted average shares · filed 2023-11-21 |
| 2021-12-31 | -$0.91 10-Q · filed 2023-02-07 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$2.57 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$3.35 derived: net income ÷ weighted average shares · filed 2023-11-21 |
| 2021-09-30 | -$0.84 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$1.65 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$2.43 derived: net income ÷ weighted average shares · filed 2023-11-21 | -$3.15 10-K · filed 2023-11-21 |
| 2021-06-30 | -$0.82 10-Q · filed 2022-08-08 | -$1.60 derived: net income ÷ weighted average shares · filed 2022-08-08 | -$2.32 10-Q · filed 2022-08-08 | |
| 2021-03-31 | -$0.78 10-Q · filed 2022-05-06 | -$1.50 10-Q · filed 2022-05-06 | ||
| 2020-09-30 | -$3.57 10-K/A · filed 2023-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |